Mingzhu Yin
- Molecular Biology top 2%
- Oncology top 5%
- Immunology top 5%
- Cancer Research top 2%
- Computational Theory and Mathematics top 0.5%
- Topics
- Protein Degradation and Inhibitors (13 papers)Cancer Immunotherapy and Biomarkers (11 papers)Metabolomics and Mass Spectrometry Studies (9 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Mingzhu Yin
128 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Molecular Biology 3.0k
- Oncology 927
- Immunology 854
- Cancer Research 801
- Computational Theory and Mathematics 711
Countries citing papers authored by Mingzhu Yin
This map shows the geographic impact of Mingzhu Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhu Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhu Yin more than expected).
Fields of papers citing papers by Mingzhu Yin
This network shows the impact of papers produced by Mingzhu Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhu Yin. The network helps show where Mingzhu Yin may publish in the future.
Co-authorship network of co-authors of Mingzhu Yin
This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhu Yin. A scholar is included among the top collaborators of Mingzhu Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhu Yin. Mingzhu Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 13 | |
| 8 | 28 | |
| 9 | 0 | |
| 10 | 22 | |
| 11 | 165 | |
| 12 | 18 | |
| 13 | 115 | |
| 14 | 15 | |
| 15 | 156 | |
| 16 | 13 | |
| 17 | 40 | |
| 18 | Betulin induces apoptosis of HeLa cell lines in vitro and its possible mechanism | 7 |
| 19 | 24 | |
| 20 | Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells. | 5 |
About Mingzhu Yin
Mingzhu Yin is a scholar working on Immunology, Cancer Research and Oncology, having authored 140 papers that have together received 6.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). The work is most often cited by research in Cancer Research (801 citations), Computational Theory and Mathematics (711 citations) and Molecular Biology (3.0k citations). Mingzhu Yin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiang Chen, Dongsheng Cao, Tingjun Hou, Aiping Lü, Zhijiang Yang, Li Fu, Chengkun Wu, Guo‐Li Xiong, Xiangxiang Zeng and Chang‐Yu Hsieh. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.